ID: ALA485562

Max Phase: Preclinical

Molecular Formula: C11H8ClN5O

Molecular Weight: 261.67

Molecule Type: Small molecule

Representations

Canonical SMILES:  Oc1ccccc1Nc1nc(Cl)nc2[nH]cnc12

Standard InChI:  InChI=1S/C11H8ClN5O/c12-11-16-9-8(13-5-14-9)10(17-11)15-6-3-1-2-4-7(6)18/h1-5,18H,(H2,13,14,15,16,17)

Standard InChI Key:  JNMZHKPRRPZPKR-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 261.67

Molecular Weight (Monoisotopic): 261.0417

AlogP: 2.46

#Rotatable Bonds: 2

Polar Surface Area: 86.72

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 9.31

CX Basic pKa: 1.05

CX LogP: 2.34

CX LogD: 2.34

Aromatic Rings: 3

Heavy Atoms: 18

QED Weighted: 0.49

Np Likeness Score: -0.90

References

1. Zatloukal M, Gemrotová M, Dolezal K, Havlícek L, Spíchal L, Strnad M..  (2008)  Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.,  16  (20): [PMID:18818088] [10.1016/j.bmc.2008.09.008]

Source

Source(1):

• Scientific Literature